Version
1.0
Date Updated
Friday, June 26, 2009
Descripton

Approved by: Interim Vice Chancellor for Research
AAHRPP REF#: 198
AAHRPP Elements: I.1.A., I.2.B,


INTRODUCTION


  1. The Central Institutional Review Board (CIRB) Initiative is sponsored by the National
    Cancer Institute (NCI) in consultation with the Department of Health and Human
    Services (DHHS) Office for Human Research Protections (OHRP).
  2. UIC has chosen to participate with NCI in this initiative, which is a "facilitated review"
    process that streamlines local IRB reviews of adult and pediatric national multicenter
    cancer treatment trials.
  3. The NCI CIRB has two panels:
    1. The Adult NCI CIRB reviews all Phase 3 Cooperative Group trials from the
      ACOSOG, CALGB, ECOG, GOG, NCCTG, NCIC, NSABP, RTOG, and
      SWOG, as well as any other studies opened in the Cancer Trials Support Unit
      (CTSU).
    2. The Pediatric NCI CIRB reviews all NCI-approved COG Phase 2, 3, and Pilot
      protocols.